Teva Pharmaceuticals Announces Launch of Generic HIV Drug
Teva Pharmaceuticals announces an exclusive launch of a generic version of atazanavir capsules for the treatment of HIV.
Cancer Mutations Triggered When Immune System Fights HIV?
According to a new study, when combatting viruses such as HIV, several enzymes in the immune system may malfunction and cause cancer-related mutations.
FDA Approves a Once Daily Treatment Option for HIV-1
The FDA approved the administration of Isentress HD in patients weighing at least 40-kg who are treatment-naïve or who achieved viral suppression from treatment with raltegravir.
HCV Infection May Cause Cancers Outside the Liver
Researchers found that HCV infection may be linked to more cancers besides hepatocellular carcinoma, as well as certain types of non-Hodgkin lymphoma.
2 Commerce Drive Cranbury, NJ 08512